Home
Catalog
Mazdutide

PEPTAURA

Home
Catalog
Mazdutide

Home Catalog Suppliers COAs Shipping Verify

Site Map

Home Catalog RFQ FAQ Verify Suppliers COAs Become an Affiliate Sellers Portal Contact

Legal

Disclaimers Privacy Policy

© 2026 peptaura.com, All Rights Reserved.

MAZDUTIDE

Dose per Vial/Pen

Latest Research

Obesity pharmacotherapy reimagined: The era of multi-receptor agonists and next-generation metabolic modulators, perspectives and controversies.

Lempesis IG, Dalamaga M

Patent landscape and therapeutic evolution of mazdutide: a dual GLP-1/Glucagon receptor agonist for obesity and type 2 diabetes.

Abdul Fasi M

Mazdutide 9 mg in Chinese adults with a body mass index ≥30 kg/m(2) but without diabetes: A phase 2 randomized controlled trial.

Ji L, Jiang H, Cheng Z, Li X, Pang S, Zhang Y, Qiu W, Ma Q, Liu Z, Wang Y, Deng H, Du H, Han-Zhang H, Qian L

Efficacy and Safety of Mazdutide in Managing Overweight and Obesity Among Non-Diabetic Adults: A Meta-Analysis of Randomised Controlled Trials.

Azam MH, Azam MH, Azam KU, Azam MA, Afridi MK, Waqas SA, Abbas MS, Aminpoor H, Ahmed R

Comparative Efficacy and Safety of Glucagon Receptor Agonists on Metabolic Outcomes: A Network Meta-Analysis of Randomised Controlled Trials.

Abulehia A, Ayesh H, Ayesh O, Jaber D, Asad T, Itbaisha A, Abugharbieh H, Gharbia R, Abu-Hilal LH, Leon BGC

Mazdutide Ameliorates Metabolic Dysfunction-Associated Steatotic Liver Disease by Modulating Endoplasmic Reticulum Stress, Improving Lipid Metabolism and Alleviating Inflammation.

Gan L, Duan L, Zheng X

Incretin-Based Dual and Triple Agonists in Overweight or Obese Individuals: A Systematic Review and Meta-Analysis.

Chan ZH, Omar AS, Gill K, Volucke G, Azhar MM, Haleem SM, Sia JE, Rahman OU, Ahmad M, Shahid N, Gardezi SA, Joseph KV, Behary Paray N, Zulfiqar E

IUPHAR review: From foe to friend: Repurposing glucagon to treat obesity and type 2 diabetes.

Elmendorf AJ, Yousefian M, Kim IM, Hardaway JA, Habegger K, Flak JN

A Clinical Comprehensive Evaluation of Long-Acting GLP-1 Receptor Agonists in Type 2 Diabetes Management.

Chen Q, Chen T, Lin W, Chen X

Research progress on multidimensional intervention strategies for hyperuricemia: Western medicine, Traditional Chinese Medicine, and emerging therapies.

Li X, Chen Z, Zhang Y, Fan C, Chen L, Xu X, Chang J, Qiang W, Jiang H, Liu C